Skip to main content
. Author manuscript; available in PMC: 2018 May 5.
Published in final edited form as: J Hepatol. 2014 Nov 27;62(4):946–955. doi: 10.1016/j.jhep.2014.11.023

Table 1.

Key sex differences in waitlist outcomes in the post-MELD era.

Waitlist times and transplant rates • Women spend longer on waitlist [2-4,7-9]
• Transplant rates are higher in men [7-9]
Waitlist mortality • Many studies note higher mortality [7,12,13] in women, but not all [9]
Size • Patient height/liver volume contribute to sex disparity in transplant rates and waitlist mortality [6,13]
Renal function • Waitlisted women have lower creatinine for similar degree of renal failure [8,12,14-16]
• Creatinine and MELD scores inadequately reflect renal dysfunction in women
Sarcopenia • Sarcopenia is strongly associated with waitlist mortality
• Women may have lower risk of sarcopenia [35]